Adjuvants, ImmunologicChemotherapy, AdjuvantFreund's AdjuvantRadiotherapy, AdjuvantAdjuvants, PharmaceuticBreast NeoplasmsAluminum HydroxideCombined Modality TherapyImmunizationTamoxifenFluorouracilAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalNeoplasm StagingAntineoplastic Agents, HormonalNeoplasm Recurrence, LocalTreatment OutcomeVaccinesAdministration, IntranasalMice, Inbred BALB CSurvival AnalysisArthritis, ExperimentalPrognosisAntibody FormationVaccines, SubunitCyclophosphamideImmunoglobulin GLymphatic MetastasisSurvival RateSqualeneVaccinationOvalbuminImmunity, MucosalLevamisoleAntineoplastic AgentsSaponinsAromatase InhibitorsPolysorbatesCholera ToxinFollow-Up StudiesAcetylmuramyl-Alanyl-IsoglutamineCancer VaccinesVaccines, SyntheticMice, Inbred C57BLMethotrexateLymph NodesRetrospective StudiesTime FactorsHypersensitivity, DelayedNeoadjuvant TherapyEpirubicinReceptors, EstrogenISCOMsVaccines, DNAMastectomyBacterial VaccinesDoxorubicinRats, Inbred LewRandomized Controlled Trials as TopicLipid AAdenocarcinomaColonic NeoplasmsImmunity, HumoralImmunity, CellularClinical Trials as TopicLeucovorinNitrilesAdjuvants, AnesthesiaDrug Administration ScheduleAntigensTh1 CellsVaccines, InactivatedKaplan-Meier EstimateAnthracyclinesHemocyaninDendritic CellsInfluenza VaccinesAntimetabolites, AntineoplasticTriazolesReceptor, erbB-2CisplatinInterferon-gammaRectal NeoplasmsDose-Response Relationship, ImmunologicQuillajaSpleenInjections, SubcutaneousAntibodies, BacterialArthritisImmunization, SecondaryT-LymphocytesCytokinesLymphocyte ActivationAntibodies, ViralImmunotherapyProportional Hazards ModelsAdministration, OralLymph Node ExcisionTegafurMelanoma